The makers of the frontrunner COVID-19 vaccine, AstraZeneca and Oxford University, were quick to downplay the illness that caused their clinical trials in five countries to come to a screeching halt earlier in September. However, the condition at the heart of the move, transverse myelitis, is actually a fairly common vaccine injury. The vaccine is being … Continue reading Myelitis observed in two COVID-19 vaccine trial participants is a common vaccine injury
